de US Bancorp Utah Medical Products UTMD Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 28.6 k | Mantener |
414
| – | – | ﹤0.01% | 3049 |
|
|
2026
Q1 | USD 25.7 k | Vender |
414
-22
| -5% | -USD 1.39 k | ﹤0.01% | 2999 |
|
|
2025
Q4 | USD 24.4 k | Comprar |
436
+22
| +5% | +USD 1.28 k | ﹤0.01% | 3001 |
|
|
2025
Q3 | USD 26.1 k | Mantener |
414
| – | – | ﹤0.01% | 2965 |
|
|
2025
Q2 | USD 23.6 k | Vender |
414
-114
| -22% | -USD 6.2 k | ﹤0.01% | 3108 |
|
|
2025
Q1 | USD 29.6 k | Vender |
528
-285
| -35% | -USD 17.1 k | ﹤0.01% | 2996 |
|
|
2024
Q4 | USD 50 k | Comprar |
813
+79
| +11% | +USD 5.11 k | ﹤0.01% | 2738 |
|
|
2024
Q3 | USD 49.1 k | Vender |
734
-193
| -21% | -USD 13.1 k | ﹤0.01% | 2748 |
|
|
2024
Q2 | USD 61.9 k | Vender |
927
-30
| -3% | -USD 2.04 k | ﹤0.01% | 2555 |
|
|
2024
Q1 | USD 68.1 k | Vender |
957
-93
| -9% | -USD 6.98 k | ﹤0.01% | 2539 |
|
|
2023
Q4 | USD 88.4 k | Mantener |
1,050
| – | – | ﹤0.01% | 2399 |
|
|
2023
Q3 | USD 90.3 k | Vender |
1,050
-22
| -2% | -USD 2.03 k | ﹤0.01% | 2196 |
|
|
2023
Q2 | USD 100 k | Vender |
1,072
-59
| -5% | -USD 5.56 k | ﹤0.01% | 2193 |
|
|
2023
Q1 | USD 107 k | Vender |
1,131
-268
| -19% | -USD 24.6 k | ﹤0.01% | 2151 |
|
|
2022
Q4 | USD 141 k | Mantener |
1,399
| – | – | ﹤0.01% | 2053 |
|
|
2022
Q3 | USD 119 k | Vender |
1,399
-43
| -3% | -USD 3.8 k | ﹤0.01% | 2115 |
|
|
2022
Q2 | USD 124 k | Comprar |
1,442
+41
| +3% | +USD 3.5 k | ﹤0.01% | 2122 |
|
|
2022
Q1 | USD 126 k | Vender |
1,401
-29
| -2% | -USD 2.67 k | ﹤0.01% | 2182 |
|
|
2021
Q4 | USD 143 k | Vender |
1,430
-126
| -8% | -USD 12.9 k | ﹤0.01% | 2121 |
|
|
2021
Q3 | USD 144 k | Mantener |
1,556
| – | – | ﹤0.01% | 2101 |
|
|
2021
Q2 | USD 132 k | Vender |
1,556
-129
| -8% | -USD 11.2 k | ﹤0.01% | 2163 |
|
|
2021
Q1 | USD 146 k | Vender |
1,685
-420
| -20% | -USD 36.9 k | ﹤0.01% | 2066 |
|
|
2020
Q4 | USD 177 k | Vender |
2,105
-574
| -21% | -USD 48.9 k | ﹤0.01% | 1923 |
|
|
2020
Q3 | USD 214 k | Vender |
2,679
-73
| -3% | -USD 6.06 k | ﹤0.01% | 1734 |
|
|
2020
Q2 | USD 244 k | Vender |
2,752
-590
| -18% | -USD 53 k | ﹤0.01% | 1655 |
|
|
2020
Q1 | USD 315 k | Vender |
3,342
-739
| -18% | -USD 68.7 k | ﹤0.01% | 1447 |
|
|
2019
Q4 | USD 440 k | Vender |
4,081
-5,097
| -56% | -USD 516 k | ﹤0.01% | 1434 |
|
|
2019
Q3 | USD 880 k | Vender |
9,178
-789
| -8% | -USD 73.3 k | ﹤0.01% | 1094 |
|
|
2019
Q2 | USD 954 k | Vender |
9,967
-112
| -1% | -USD 9.43 k | ﹤0.01% | 1091 |
|
|
2019
Q1 | USD 889 k | Vender |
10,079
-387
| -4% | -USD 34 k | ﹤0.01% | 1118 |
|
|
2018
Q4 | USD 869 k | Vender |
10,466
-3
| -0% | -USD 264 | ﹤0.01% | 1082 |
|
|
2018
Q3 | USD 986 k | Vender |
10,469
-444
| -4% | -USD 42.4 k | ﹤0.01% | 1109 |
|
|
2018
Q2 | USD 1.2 M | Vender |
10,913
-1,216
| -10% | -USD 127 k | ﹤0.01% | 1019 |
|
|
2018
Q1 | USD 1.2 M | Vender |
12,129
-185
| -2% | -USD 16.5 k | ﹤0.01% | 1001 |
|
|
2017
Q4 | USD 1 M | Comprar |
12,314
+120
| +1% | +USD 9.37 k | ﹤0.01% | 1096 |
|
|
2017
Q3 | USD 897 k | Vender |
12,194
-430
| -3% | -USD 30.9 k | ﹤0.01% | 1142 |
|
|
2017
Q2 | USD 914 k | Vender |
12,624
-1,515
| -11% | -USD 100 k | ﹤0.01% | 1092 |
|
|
2017
Q1 | USD 880 k | Vender |
14,139
-1,041
| -7% | -USD 65.5 k | ﹤0.01% | 1137 |
|
|
2016
Q4 | USD 1.1 M | Vender |
15,180
-460
| -3% | -USD 29.9 k | ﹤0.01% | 1019 |
|
|
2016
Q3 | USD 936 k | Vender |
15,640
-3,404
| -18% | -USD 217 k | ﹤0.01% | 1058 |
|
|
2016
Q2 | USD 1.2 M | Vender |
19,044
-3,528
| -16% | -USD 228 k | ﹤0.01% | 914 |
|
|
2016
Q1 | USD 1.41 M | Vender |
22,572
-7,653
| -25% | -USD 451 k | 0.01% | 819 |
|
|
2015
Q4 | USD 1.77 M | Vender |
30,225
-1,404
| -4% | -USD 79.6 k | 0.01% | 737 |
|
|
2015
Q3 | USD 1.7 M | Vender |
31,629
-2,309
| -7% | -USD 126 k | 0.01% | 748 |
|
|
2015
Q2 | USD 2.02 M | Vender |
33,938
-26
| -0.1% | -USD 1.46 k | 0.01% | 722 |
|
|
2015
Q1 | USD 2.03 M | Comprar |
33,964
+323
| +1% | +USD 19 k | 0.01% | 714 |
|
|
2014
Q4 | USD 2.02 M | Comprar |
33,641
+494
| +1% | +USD 27.4 k | 0.01% | 700 |
|
|
2014
Q3 | USD 1.62 M | Vender |
33,147
-230
| -0.7% | -USD 11.7 k | 0.01% | 766 |
|
|
2014
Q2 | USD 1.72 M | Vender |
33,377
-1,348
| -4% | -USD 69.2 k | 0.01% | 755 |
|
|
2014
Q1 | USD 2.01 M | Vender |
34,725
-587
| -2% | -USD 32 k | 0.01% | 692 |
|
|
2013
Q4 | USD 2.02 M | Vender |
35,312
-3,333
| -9% | -USD 183 k | 0.01% | 662 |
|
|
2013
Q3 | USD 2.3 M | Comprar |
38,645
+370
| +1% | +USD 20.2 k | 0.01% | 584 |
|
|
2013
Q2 | USD 2.08 M | Comprar |
+38,275
| Nuevas | +USD 1.8 M | 0.01% | 589 |
|
Otros fondos que tienen UTMD en su cartera
MA
Posición de US Bancorp en UTMD: resumen de T2 2026
US Bancorp mantuvo sin cambios su posición en Utah Medical Products (UTMD) en T2 2026, con 414 acciones por un valor de USD 28.6 k. La posición representa ﹤0.01% de la cartera y ocupa el puesto #3049.
US Bancorp reportó por primera vez una posición en UTMD en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. La posición alcanzó su máximo de USD 2.3 M en T3 2013. Al cierre de T2 2026, 114 fondos que sigue Wall St. Rank mantienen una posición en UTMD.
- Al cierre de T2 2026, US Bancorp tenía 414 acciones de Utah Medical Products con un valor de USD 28.6 k.
- US Bancorp mantuvo sin cambios su número de acciones de Utah Medical Products en T2 2026.
- Utah Medical Products representó ﹤0.01% de la cartera de US Bancorp en T2 2026 y fue su posición número 3049.
- US Bancorp reportó por primera vez una posición en Utah Medical Products en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- La posición de US Bancorp en Utah Medical Products alcanzó su máximo de USD 2.3 M en T3 2013.
- Al cierre de T2 2026, 114 fondos que sigue Wall St. Rank tenían Utah Medical Products en cartera.
Según el Informe 13F de US Bancorp correspondiente a T2 2026, presentado el 12 ago 2026.